Dr Sulaiman Al Habib Medical Services Group Company SJSC 4013.SR · SAR

Health Care · Health Care Providers & Services · Tadawul · 🇸🇦 Saudi Arabia

Compare

214.20

-0.37%

Close of 9 Nov 2026, in SAR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SAR, from our data supplier.

FY2025

Revenue

SAR 13.71bn

FY2016FY2025

Net income

SAR 2.40bn

FY2016FY2025

Free cash flow

SAR 101.3m

FY2016FY2025

Shareholders' equity

SAR 7.90bn

FY2016FY2025

Income statement

Fiscal years

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Revenue	SAR 13.71bn	SAR 11.20bn	SAR 9.51bn	SAR 8.31bn	SAR 7.25bn	SAR 5.86bn	SAR 5.02bn	SAR 4.59bn	SAR 4.38bn	SAR 4.87bn
Operating income	SAR 2.64bn	SAR 2.57bn	SAR 2.24bn	SAR 1.84bn	SAR 1.54bn	SAR 1.18bn	SAR 936.6m	SAR 810.0m	SAR 662.8m	SAR 922.3m
Net income	SAR 2.40bn	SAR 2.32bn	SAR 2.05bn	SAR 1.65bn	SAR 1.38bn	SAR 1.06bn	SAR 870.2m	SAR 801.3m	SAR 656.2m	SAR 1.01bn
Diluted earnings per share	7.52	6.62	5.85	4.72	3.93	3.02	2.49	2.29	1.87	2.89

Balance sheet

At each fiscal year end

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Total assets	SAR 23.21bn	SAR 20.56bn	SAR 15.80bn	SAR 12.58bn	SAR 10.83bn	SAR 9.48bn	SAR 8.47bn	SAR 7.54bn	SAR 7.00bn	SAR 6.73bn
Cash and short-term investments	SAR 2.28bn	SAR 2.89bn	SAR 2.62bn	SAR 2.75bn	SAR 2.64bn	SAR 2.34bn	SAR 1.20bn	SAR 1.37bn	SAR 1.14bn	SAR 871.3m
Total liabilities	SAR 14.78bn	SAR 12.95bn	SAR 9.03bn	SAR 6.48bn	SAR 5.30bn	SAR 4.39bn	SAR 3.88bn	SAR 2.94bn	SAR 2.45bn	SAR 2.31bn
Debt	SAR 8.93bn	SAR 8.17bn	SAR 5.18bn	SAR 3.52bn	SAR 3.05bn	SAR 2.63bn	SAR 2.34bn	SAR 1.57bn	SAR 1.21bn	SAR 276.4m
Shareholders' equity	SAR 7.90bn	SAR 7.18bn	SAR 6.49bn	SAR 5.88bn	SAR 5.34bn	SAR 4.91bn	SAR 4.39bn	SAR 4.33bn	SAR 4.32bn	SAR 4.27bn
Shares outstanding	319m	350m	350m	350m	350m	350m	350m	350m	350m	350m

Cash flow

Fiscal years

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016
Cash from operations	SAR 3.08bn	SAR 2.97bn	SAR 3.24bn	SAR 2.84bn	SAR 2.18bn	SAR 2.18bn	SAR 1.06bn	SAR 1.43bn	SAR 1.08bn	SAR 899.9m
Capital spending	−SAR 2.98bn	−SAR 3.83bn	−SAR 3.50bn	−SAR 1.51bn	−SAR 1.25bn	−SAR 757.7m	−SAR 732.9m	−SAR 830.1m	−SAR 421.4m	−SAR 1.24bn
Free cash flow	SAR 101.3m	−SAR 858.2m	−SAR 252.7m	SAR 1.33bn	SAR 929.3m	SAR 1.42bn	SAR 326.2m	SAR 604.5m	SAR 661.7m	−SAR 342.3m
Dividends paid	−SAR 1.66bn	−SAR 1.64bn	−SAR 1.44bn	−SAR 1.14bn	−SAR 945.0m	−SAR 525.0m	−SAR 903.4m	−SAR 788.5m	−SAR 517.0m	−SAR 199.9m

Latest quarters

By quarter end

	Jun 2026	Mar 2026	Dec 2025	Sept 2025	Jun 2025	Mar 2025	Dec 2024	Sept 2024
Revenue	SAR 4.01bn	SAR 3.44bn	SAR 3.70bn	SAR 3.46bn	SAR 3.38bn	SAR 3.16bn	SAR 3.13bn	SAR 2.98bn
Operating income	SAR 770.4m	SAR 587.7m	SAR 702.8m	SAR 665.7m	SAR 644.9m	SAR 625.9m	SAR 657.3m	SAR 624.4m
Net income	SAR 662.7m	SAR 503.3m	SAR 651.2m	SAR 602.3m	SAR 591.0m	SAR 557.0m	SAR 613.8m	SAR 595.5m
Diluted earnings per share	1.89	1.44	2.04	1.89	1.85	1.74	1.75	1.70
Cash from operations	SAR 777.0m	SAR 1.05bn	SAR 946.0m	SAR 1.10bn	SAR 462.0m	SAR 733.0m	SAR 1.09bn	SAR 972.0m
Capital spending	−SAR 563.0m	−SAR 472.0m	−SAR 512.0m	−SAR 786.0m	−SAR 749.0m	−SAR 934.0m	−SAR 948.0m	−SAR 897.0m
Free cash flow	SAR 214.0m	SAR 582.0m	SAR 434.0m	SAR 315.0m	−SAR 287.0m	−SAR 201.0m	SAR 142.0m	SAR 75.0m
Total assets	SAR 24.69bn	SAR 23.77bn	SAR 23.21bn	SAR 22.79bn	SAR 22.48bn	SAR 21.36bn	SAR 20.56bn	SAR 19.22bn
Cash and short-term investments	—	—	SAR 2.28bn	SAR 2.11bn	SAR 2.18bn	SAR 2.55bn	SAR 2.89bn	SAR 2.38bn
Debt	SAR 8.94bn	SAR 8.98bn	SAR 8.93bn	SAR 190.8m	SAR 8.67bn	SAR 8.24bn	SAR 7.83bn	SAR 6.99bn
Shareholders' equity	SAR 8.26bn	SAR 7.95bn	SAR 7.90bn	SAR 7.68bn	SAR 7.49bn	SAR 7.29bn	SAR 7.18bn	SAR 6.99bn

Financial ratios

Data as of 10 Sept 2026

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
Operating margin	19.3%	23.0%	23.6%	22.1%	21.3%	20.1%
Net margin	17.5%	20.7%	21.5%	19.9%	19.0%	18.0%
Return on equity	30.4%	32.3%	31.5%	28.1%	25.8%	21.5%
Return on assets	10.3%	11.3%	13.0%	13.1%	12.7%	11.1%
Free cash flow yield	8.2%	8.4%	8.3%	5.4%	4.2%	3.6%
Revenue growth	22.4%	17.8%	14.4%	14.6%	23.7%	16.9%
Earnings growth	3.7%	13.2%	23.9%	19.9%	30.4%	21.3%
Current ratio	1.15x	1.28x	1.25x	1.61x	2.02x	2.27x
Debt to equity	1.13x	1.09x	0.76x	0.55x	0.52x	0.49x
Equity ratio	34.0%	34.9%	41.1%	46.7%	49.3%	51.8%
Interest coverage	7.35x	14.32x	26.70x	30.18x	31.74x	21.80x
Buybacks as a share of market value	8.7%	0.0%	0.0%	0.0%	0.0%	0.0%

Growth per year

Compound annual rate

	3 years	5 years	10 years
Revenue	18.1%	18.5%	10.3%
Operating income	12.8%	17.5%	6.9%
Net income	13.3%	17.9%	6.1%

Average margins

Over each period

	1 year	3 years	5 years	10 years
Operating margin	20.9%	21.7%	21.5%	20.9%
Net margin	18.9%	19.7%	19.4%	19.4%

Valuation history

At each fiscal year end

	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
Price to earnings	34.2	42.4	48.6	46.8	41.0	36.1
Price to sales	6.0	8.8	10.4	9.3	7.8	6.5

Dividends and splits

Per share, in the currency the company pays

Paid for 6 years. Last went ex-dividend on 2 Aug 2026.

	FY2026	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020
Paid in the year	3.65	4.75	4.69	4.10	3.25	2.70	1.50

Sources and methodology

Data on this tab: Our data supplier
Chart on the Overview: TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.

Asset classes

Countries / Regions

Market tools

News & insights

Dr Sulaiman Al Habib Medical Services Group Company SJSC 4013.SR · SAR

Search any instrument

At a glance

Income statement

Balance sheet

Cash flow

Latest quarters

Financial ratios

Growth per year

Average margins

Valuation history

Dividends and splits

Sources and methodology